Proarrhythmic risk assessment using conventional and new in vitro assays
Sonia Goineau1, Vincent Castagné1
1Porsolt, Z.A. de Glatigné, 53940 Le Genest-Saint-Isle, France.
Abstract:
Drug-induced QT prolongation is a major safety issue in the drug discovery process. This study was conducted to assess the electrophysiological responses of four substances using established preclinical assays usually used in regulatory studies (hERG channel or Purkinje fiber action potential) and a new assay (human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)-field potential). After acute exposure, moxifloxacin and dofetilide concentration-dependently decreased IKr amplitude (IC50 values: 102 μM and 40 nM, respectively) and lengthened action potential (100 μM moxifloxacin: +23% and 10 nM dofetilide: +18%) and field potential (300 μM moxifloxacin: +76% and 10 nM dofetilide: +38%) durations. Dofetilide starting from 30 nM induced arrhythmia in hiPSC-CMs. Overnight application of pentamidine (10 and 100 μM) and arsenic (1 and 10 μM) decreased IKr, whereas they were devoid of effects after acute application. Long-term pentamidine incubation showed a time- and concentration-dependent effect on field potential duration. In conclusion, our data suggest that hiPSC-CMs represent a fully functional cellular electrophysiology model which may significantly improve the predictive validity of in vitro safety studies. Thereafter, lead candidates may be further investigated in patch-clamp assays for mechanistic studies on individual ionic channels or in a multicellular Purkinje fiber preparation for confirmatory studies on cardiac conduction.
Insights
This study highlights human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as a predictive in vitro model for assessing drug-induced cardiac safety. hiPSC-CMs accurately identified QT prolongation risks, improving drug discovery safety evaluations.
Area of Science:
- Cardiovascular Pharmacology
- Drug Safety Evaluation
- Stem Cell Biology
Background:
- Drug-induced QT prolongation poses significant risks during drug development.
- Established preclinical assays like hERG channel and Purkinje fiber action potential assays are used for safety assessments.
Purpose of the Study:
- To evaluate the electrophysiological responses of four substances using traditional assays and a novel human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)-field potential assay.
- To assess the predictive validity of hiPSC-CMs for identifying drug-induced cardiac safety issues.
Main Methods:
- Utilized established preclinical assays (hERG channel, Purkinje fiber action potential) and a new hiPSC-CMs-field potential assay.
- Assessed acute and overnight exposure effects of moxifloxacin, dofetilide, pentamidine, and arsenic on electrophysiological parameters.
Main Results:
- Moxifloxacin and dofetilide concentration-dependently decreased IKr amplitude and lengthened action and field potential durations.
- Dofetilide induced arrhythmia in hiPSC-CMs at 30 nM.
- Pentamidine and arsenic showed effects on IKr and field potential duration after overnight incubation, but not acute exposure.
Conclusions:
- hiPSC-CMs serve as a functional cellular electrophysiology model that enhances the predictive validity of in vitro safety studies.
- This model can improve early-stage drug safety assessments, potentially reducing late-stage failures.
More Related Videos
Related Concept Videos
Dysrhythmias V: Evaluating Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias


